InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,886.62
(
0.15%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

terry hallinan

Send PM Follow Ignore
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

terry hallinan

Re: biotech_researcher post# 415

Friday, 08/03/2018 4:42:10 PM

Friday, August 03, 2018 4:42:10 PM

Post# of 438
Blue, Biotech;

This is from a transcript of the earnings teleconference from St. Peter, PETX CEO:

Regarding our second quarter 2018 financial results, as reported in our earnings release issued last evening, our total net revenues for the second quarter ended June 30, 2018 were $4.9 million. This compares to $5.2 million in the second quarter of 2017 which as a reminder included $3.7 million in product sales of the GALLIPRANT finished goods to Elanco.

Nothing to go wild over but PETX's own sales look a smidgen better.

Best, Terry
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up